# Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity

Study · id `cardio:ct-nct02208765` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02208765](<https://clinicaltrials.gov/study/NCT02208765>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02208765

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1600 participants.

## Technical summary

Registry record NCT02208765. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-01 (actual); primary completion 2022-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 1600 participants (planned count; ClinicalTrials.gov record NCT02208765, source copy `cardio:ctgov-nct02208765-2022-05-19`, retrieved 2026-10-26)
- Started: 2015-01 (actual) (ClinicalTrials.gov record NCT02208765, source copy `cardio:ctgov-nct02208765-2022-05-19`, retrieved 2026-10-26)
- Primary completion: 2022-06 (anticipated) (ClinicalTrials.gov record NCT02208765, source copy `cardio:ctgov-nct02208765-2022-05-19`, retrieved 2026-10-26)
- Completion: 2022-06 (anticipated) (ClinicalTrials.gov record NCT02208765, source copy `cardio:ctgov-nct02208765-2022-05-19`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02208765, source copy `cardio:ctgov-nct02208765-2022-05-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02208765-2022-05-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
- Acronym: EVAPERF
- Condition: Coronary Artery Disease
- Condition: Coronary Atherosclerosis
- Intervention (Device): Stress Single Photon Emission Computed Tomography
- Lead sponsor: University Hospital, Grenoble
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Grenoble (`cardio:org-university-hospital-grenoble`)

## Provenance

Content hash: 6bf60f7713fc0291f9ee4810d5c5be5a29c9dc78293fc6c719e9708f85c5b2de
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
